These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Relative efficacy. When the government decides what drug should be prescribed, is the patient better served? J Med Assoc State Ala; 1972 Sep; 42(3):200-12. PubMed ID: 5070864 [No Abstract] [Full Text] [Related]
69. Proper and improper interpretation of drug and chemical information. Workshop summary. Tuchmann-Duplessis H. Prog Clin Biol Res; 1985 Sep; 163C():145-6. PubMed ID: 3991616 [No Abstract] [Full Text] [Related]
73. How does the FDA affect you and your practice? Novitch M. Leg Aspects Med Pract; 1979 Mar; 7(3):23-6. PubMed ID: 423685 [No Abstract] [Full Text] [Related]
77. Caution advised in interpretation of US FDA risk classification for dermatological medications during pregnancy. Wong JW, Heller MM, Murase JE. Dermatol Online J; 2012 Oct 15; 18(10):15. PubMed ID: 23122022 [Abstract] [Full Text] [Related]
78. Opioid peptides as drug products: FDA regulatory requirements. Hoiberg CP, Rapaka RS. NIDA Res Monogr; 1986 Oct 15; 70():385-404. PubMed ID: 3093882 [No Abstract] [Full Text] [Related]